$ANIK Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Anika Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Anika Therapeutics, Inc.. Get notifications about new insider transactions in Anika Therapeutics, Inc. for free.
Page: < prev 1 2 3 4 5 6 ... 6 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 08 2016 | ANIK | Anika Therapeutics ... | Hague Richard | Chief Commercial Of ... | Grant | A | 0.00 | 7,900 | 0 | 28,900 | 21 K to 28.9 K (+37.62 %) |
| Feb 08 2016 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President, CEO, Dir ... | Option Exercise | A | 38.11 | 63,500 | 2,419,985 | 63,500 | |
| Feb 08 2016 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President, CEO, Dir ... | Grant | A | 0.00 | 22,600 | 0 | 264,055 | 241.5 K to 264.1 K (+9.36 %) |
| Feb 08 2016 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Option Exercise | A | 38.11 | 18,300 | 697,413 | 18,300 | |
| Feb 08 2016 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Grant | A | 0.00 | 7,900 | 0 | 32,725 | 24.8 K to 32.7 K (+31.82 %) |
| Feb 08 2016 | ANIK | Anika Therapeutics ... | Larsen Glenn R. | Director | Grant | A | 0.00 | 2,361 | 0 | 4,483 | 2.1 K to 4.5 K (+111.26 %) |
| Feb 08 2016 | ANIK | Anika Therapeutics ... | BOWER JOSEPH I | Director | Grant | A | 0.00 | 2,361 | 0 | 36,973 | 34.6 K to 37 K (+6.82 %) |
| Feb 08 2016 | ANIK | Anika Therapeutics ... | Ahn Edward S. | Chief Tech & Strate ... | Option Exercise | A | 38.11 | 18,300 | 697,413 | 18,300 | |
| Feb 08 2016 | ANIK | Anika Therapeutics ... | Ahn Edward S. | Chief Tech & Strate ... | Grant | A | 0.00 | 7,900 | 0 | 7,900 | 0 to 7.9 K |
| Jan 28 2016 | ANIK | Anika Therapeutics ... | BOWER JOSEPH I | Director | Option Exercise | M | 10.51 | 1,770 | 18,603 | 0 | |
| Jan 28 2016 | ANIK | Anika Therapeutics ... | BOWER JOSEPH I | Director | Payment of Exercise | F | 38.33 | 486 | 18,628 | 34,612 | 35.1 K to 34.6 K (-1.38 %) |
| Jan 28 2016 | ANIK | Anika Therapeutics ... | BOWER JOSEPH I | Director | Buy | M | 10.51 | 1,770 | 18,603 | 35,098 | 33.3 K to 35.1 K (+5.31 %) |
| Jan 28 2016 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Option Exercise | M | 10.51 | 1,770 | 18,603 | 0 | |
| Jan 28 2016 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Payment of Exercise | F | 38.33 | 486 | 18,628 | 30,636 | 31.1 K to 30.6 K (-1.56 %) |
| Jan 28 2016 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Buy | M | 10.51 | 1,770 | 18,603 | 31,122 | 29.4 K to 31.1 K (+6.03 %) |
| Oct 28 2015 | ANIK | Anika Therapeutics ... | Hague Richard | Chief Commercial Of ... | Grant | A | 0.00 | 21,000 | 0 | 21,000 | 0 to 21 K |
| Aug 11 2015 | ANIK | Anika Therapeutics ... | Moran John C | Director | Sell | S | 36.18 | 2,000 | 72,360 | 14,803 | 16.8 K to 14.8 K (-11.90 %) |
| Aug 06 2015 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Sell | J | 0.00 | 2,303 | 0 | 29,352 | 31.7 K to 29.4 K (-7.28 %) |
| Aug 03 2015 | ANIK | Anika Therapeutics ... | LAND RAYMOND J | Director | Option Exercise | M | 12.36 | 1,540 | 19,034 | 0 | |
| Aug 03 2015 | ANIK | Anika Therapeutics ... | LAND RAYMOND J | Director | Sell | S | 37.76 | 1,018 | 38,440 | 14,499 | 15.5 K to 14.5 K (-6.56 %) |
| Aug 03 2015 | ANIK | Anika Therapeutics ... | LAND RAYMOND J | Director | Payment of Exercise | F | 36.51 | 522 | 19,058 | 15,517 | 16 K to 15.5 K (-3.25 %) |
| Aug 03 2015 | ANIK | Anika Therapeutics ... | LAND RAYMOND J | Director | Buy | M | 12.36 | 1,540 | 19,034 | 16,039 | 14.5 K to 16 K (+10.62 %) |
| Aug 03 2015 | ANIK | Anika Therapeutics ... | LAND RAYMOND J | Director | Sell | S | 37.39 | 690 | 25,799 | 14,499 | 15.2 K to 14.5 K (-4.54 %) |
| Aug 03 2015 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Option Exercise | M | 12.61 | 5,000 | 63,050 | 0 | |
| Aug 03 2015 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Buy | M | 12.61 | 5,000 | 63,050 | 24,825 | 19.8 K to 24.8 K (+25.22 %) |
| May 29 2015 | ANIK | Anika Therapeutics ... | Moran John C | Director | Sell | S | 33.00 | 2,500 | 82,500 | 16,803 | 19.3 K to 16.8 K (-12.95 %) |
| Mar 02 2015 | ANIK | Anika Therapeutics ... | Moran John C | Director | Sell | S | 39.61 | 2,500 | 99,025 | 19,303 | 21.8 K to 19.3 K (-11.47 %) |
| Mar 02 2015 | ANIK | Anika Therapeutics ... | LAND RAYMOND J | Director | Option Exercise | A | 10.51 | 1,770 | 18,603 | 0 | |
| Mar 02 2015 | ANIK | Anika Therapeutics ... | LAND RAYMOND J | Director | Option Exercise | A | 10.50 | 4,500 | 47,250 | 0 | |
| Mar 02 2015 | ANIK | Anika Therapeutics ... | LAND RAYMOND J | Director | Sell | S | 39.49 | 4,621 | 182,483 | 15,189 | 19.8 K to 15.2 K (-23.33 %) |
| Mar 02 2015 | ANIK | Anika Therapeutics ... | LAND RAYMOND J | Director | Payment of Exercise | F | 39.96 | 1,649 | 65,894 | 19,810 | 21.5 K to 19.8 K (-7.68 %) |
| Mar 02 2015 | ANIK | Anika Therapeutics ... | LAND RAYMOND J | Director | Buy | M | 10.51 | 1,770 | 18,603 | 21,459 | 19.7 K to 21.5 K (+8.99 %) |
| Mar 02 2015 | ANIK | Anika Therapeutics ... | LAND RAYMOND J | Director | Buy | M | 10.50 | 4,500 | 47,250 | 19,689 | 15.2 K to 19.7 K (+29.63 %) |
| Feb 19 2015 | ANIK | Anika Therapeutics ... | Larsen Glenn R. | Director | Grant | A | 0.00 | 2,122 | 0 | 2,122 | 0 to 2.1 K |
| Feb 05 2015 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | Chief Operating Off ... | Option Exercise | A | 39.69 | 3,100 | 123,039 | 0 | |
| Feb 05 2015 | ANIK | Anika Therapeutics ... | LAND RAYMOND J | Director | Grant | A | 0.00 | 1,511 | 0 | 15,189 | 13.7 K to 15.2 K (+11.05 %) |
| Feb 05 2015 | ANIK | Anika Therapeutics ... | Moran John C | Director | Grant | A | 0.00 | 1,511 | 0 | 21,803 | 20.3 K to 21.8 K (+7.45 %) |
| Feb 05 2015 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Option Exercise | M | 8.71 | 50,000 | 435,500 | 0 | |
| Feb 05 2015 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Option Exercise | A | 32.02 | 16,600 | 531,532 | 16,600 | |
| Feb 05 2015 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Option Exercise | A | 39.69 | 34,200 | 1,357,398 | 34,200 | |
| Feb 05 2015 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Grant | A | 8.71 | 50,000 | 435,500 | 241,455 | 191.5 K to 241.5 K (+26.12 %) |
| Feb 05 2015 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Grant | A | 0.00 | 13,500 | 0 | 191,455 | 178 K to 191.5 K (+7.59 %) |
| Feb 05 2015 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Option Exercise | A | 32.02 | 4,600 | 147,292 | 4,600 | |
| Feb 05 2015 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Option Exercise | A | 39.69 | 13,700 | 543,753 | 13,700 | |
| Feb 05 2015 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Grant | A | 0.00 | 6,675 | 0 | 19,825 | 13.2 K to 19.8 K (+50.76 %) |
| Feb 05 2015 | ANIK | Anika Therapeutics ... | Thompson Jeffery S | Director | Grant | A | 0.00 | 1,511 | 0 | 12,587 | 11.1 K to 12.6 K (+13.64 %) |
| Feb 05 2015 | ANIK | Anika Therapeutics ... | BOWER JOSEPH I | Director | Grant | A | 0.00 | 1,511 | 0 | 33,328 | 31.8 K to 33.3 K (+4.75 %) |
| Feb 05 2015 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Option Exercise | M | 14.33 | 1,275 | 18,271 | 0 | |
| Feb 05 2015 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Grant | A | 14.33 | 1,275 | 18,271 | 31,655 | 30.4 K to 31.7 K (+4.20 %) |
| Feb 05 2015 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Grant | A | 0.00 | 1,511 | 0 | 30,380 | 28.9 K to 30.4 K (+5.23 %) |
| Jan 28 2015 | ANIK | Anika Therapeutics ... | BOWER JOSEPH I | Director | Option Exercise | M | 14.33 | 1,275 | 18,271 | 0 | |
| Jan 28 2015 | ANIK | Anika Therapeutics ... | BOWER JOSEPH I | Director | Grant | A | 14.33 | 1,275 | 18,271 | 31,817 | 30.5 K to 31.8 K (+4.17 %) |
| Nov 03 2014 | ANIK | Anika Therapeutics ... | Ahn Edward S. | Chief Tech. & Strat ... | Option Exercise | A | 41.15 | 40,000 | 1,646,000 | 40,000 | |
| Jun 16 2014 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Sell | J | 0.00 | 22,753 | 0 | 28,869 | 51.6 K to 28.9 K (-44.08 %) |
| Jun 03 2014 | ANIK | Anika Therapeutics ... | Moran John C | Director | Sell | S | 48.41 | 2,000 | 96,820 | 20,292 | 22.3 K to 20.3 K (-8.97 %) |
| May 07 2014 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Option Exercise | A | 6.36 | 100,000 | 636,000 | 0 | |
| May 07 2014 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Option Exercise | A | 3.05 | 82,000 | 250,100 | 0 | |
| May 07 2014 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Option Exercise | A | 10.99 | 57,530 | 632,255 | 0 | |
| May 07 2014 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Option Exercise | A | 12.36 | 49,000 | 605,640 | 0 | |
| May 07 2014 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Option Exercise | A | 10.51 | 49,000 | 514,990 | 0 | |
| May 07 2014 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Payment of Exercise | F | 47.46 | 189,381 | 8,988,022 | 177,955 | 367.3 K to 178 K (-51.56 %) |
| May 07 2014 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Buy | M | 6.36 | 100,000 | 636,000 | 367,336 | 267.3 K to 367.3 K (+37.41 %) |
| May 07 2014 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Buy | M | 3.05 | 82,000 | 250,100 | 267,336 | 185.3 K to 267.3 K (+44.24 %) |
| May 07 2014 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Buy | M | 10.99 | 57,530 | 632,255 | 185,336 | 127.8 K to 185.3 K (+45.01 %) |
| May 07 2014 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Buy | M | 12.36 | 49,000 | 605,640 | 127,806 | 78.8 K to 127.8 K (+62.18 %) |
| May 07 2014 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Buy | M | 10.51 | 49,000 | 514,990 | 78,806 | 29.8 K to 78.8 K (+164.40 %) |
| May 05 2014 | ANIK | Anika Therapeutics ... | Thompson Jeffery S | Director | Sell | S | 45.82 | 10,346 | 474,054 | 11,076 | 21.4 K to 11.1 K (-48.30 %) |
| May 02 2014 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Sell | S | 44.32 | 83,780 | 3,713,130 | 29,806 | 113.6 K to 29.8 K (-73.76 %) |
| Mar 03 2014 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Sell | S | 41.09 | 150,000 | 6,163,500 | 113,586 | 263.6 K to 113.6 K (-56.91 %) |
| Mar 03 2014 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Sell | S | 43.53 | 50,000 | 2,176,500 | 263,586 | 313.6 K to 263.6 K (-15.94 %) |
| Mar 03 2014 | ANIK | Anika Therapeutics ... | LAND RAYMOND J | Director | Sell | S | 43.47 | 8,914 | 387,492 | 13,678 | 22.6 K to 13.7 K (-39.46 %) |
| Jan 30 2014 | ANIK | Anika Therapeutics ... | LAND RAYMOND J | Director | Grant | A | 0.00 | 1,873 | 0 | 22,592 | 20.7 K to 22.6 K (+9.04 %) |
| Jan 29 2014 | ANIK | Anika Therapeutics ... | BARNETT CAROL A | Chief Commercial Of ... | Option Exercise | A | 32.02 | 13,800 | 441,876 | 13,800 | |
| Jan 29 2014 | ANIK | Anika Therapeutics ... | BARNETT CAROL A | Chief Commercial Of ... | Grant | A | 0.00 | 6,100 | 0 | 6,100 | 0 to 6.1 K |
| Jan 29 2014 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | Chief Executive Off ... | Option Exercise | A | 32.02 | 35,000 | 1,120,700 | 35,000 | |
| Jan 29 2014 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | Chief Executive Off ... | Grant | A | 0.00 | 15,500 | 0 | 313,586 | 298.1 K to 313.6 K (+5.20 %) |
| Jan 29 2014 | ANIK | Anika Therapeutics ... | Cheung Sylvia | CFO | Option Exercise | A | 32.02 | 13,800 | 441,876 | 13,800 | |
| Jan 29 2014 | ANIK | Anika Therapeutics ... | Cheung Sylvia | CFO | Grant | A | 0.00 | 6,100 | 0 | 13,150 | 7.1 K to 13.2 K (+86.52 %) |
| Jan 29 2014 | ANIK | Anika Therapeutics ... | Thompson Jeffery S | Director | Grant | A | 0.00 | 1,873 | 0 | 21,422 | 19.5 K to 21.4 K (+9.58 %) |
| Jan 29 2014 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Grant | A | 0.00 | 1,873 | 0 | 51,622 | 49.7 K to 51.6 K (+3.76 %) |
| Jan 29 2014 | ANIK | Anika Therapeutics ... | BOWER JOSEPH I | Director | Grant | A | 0.00 | 1,873 | 0 | 30,542 | 28.7 K to 30.5 K (+6.53 %) |
| Jan 29 2014 | ANIK | Anika Therapeutics ... | Moran John C | Director | Grant | A | 0.00 | 1,873 | 0 | 22,292 | 20.4 K to 22.3 K (+9.17 %) |
| Dec 12 2013 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Option Exercise | M | 9.22 | 1,530 | 14,107 | 0 | |
| Dec 12 2013 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Grant | A | 0.00 | 1,530 | 0 | 49,749 | 48.2 K to 49.7 K (+3.17 %) |
| Dec 03 2013 | ANIK | Anika Therapeutics ... | BOWER JOSEPH I | Director | Option Exercise | M | 9.22 | 1,530 | 14,107 | 0 | |
| Dec 03 2013 | ANIK | Anika Therapeutics ... | BOWER JOSEPH I | Director | Grant | A | 0.00 | 1,530 | 0 | 28,669 | 27.1 K to 28.7 K (+5.64 %) |
| Oct 04 2013 | ANIK | Anika Therapeutics ... | SHEETS JOHN W JR | Chief Scientific Of ... | Option Exercise | A | 25.46 | 30,000 | 763,800 | 30,000 | |
| Oct 04 2013 | ANIK | Anika Therapeutics ... | SHEETS JOHN W JR | Chief Scientific Of ... | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
| Aug 26 2013 | ANIK | Anika Therapeutics ... | Moran John C | Director | Sell | S | 24.35 | 5,000 | 121,750 | 20,419 | 25.4 K to 20.4 K (-19.67 %) |
| Aug 09 2013 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Sell | S | 23.61 | 26,984 | 637,092 | 48,219 | 75.2 K to 48.2 K (-35.88 %) |
| Aug 08 2013 | ANIK | Anika Therapeutics ... | Fidia Farmaceutici S.p.A. | 10% Owner | Sell | S | 24.52 | 1,270,000 | 31,140,400 | 711,192 | 2 M to 711.2 K (-64.10 %) |
| Aug 08 2013 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Sell | S | 24.99 | 1,098 | 27,439 | 75,203 | 76.3 K to 75.2 K (-1.44 %) |
| Aug 08 2013 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Sell | S | 27.23 | 9,918 | 270,067 | 76,301 | 86.2 K to 76.3 K (-11.50 %) |
| Jul 15 2013 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Option Exercise | M | 9.22 | 14,306 | 131,901 | 0 | |
| Jul 15 2013 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Sell | S | 20.63 | 10,456 | 215,707 | 298,086 | 308.5 K to 298.1 K (-3.39 %) |
| Jul 15 2013 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Sell | S | 20.03 | 64,544 | 1,292,816 | 308,542 | 373.1 K to 308.5 K (-17.30 %) |
| Jul 15 2013 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Sell | M | 9.22 | 14,306 | 131,901 | 373,086 | 387.4 K to 373.1 K (-3.69 %) |
| Jul 10 2013 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Option Exercise | M | 9.22 | 1,321 | 12,180 | 0 | |
| Jul 10 2013 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Option Exercise | M | 9.22 | 47,864 | 441,306 | 1,321 | |
| Jul 10 2013 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Sell | S | 18.11 | 1,321 | 23,923 | 358,780 | 360.1 K to 358.8 K (-0.37 %) |
| Jul 10 2013 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Buy | M | 9.22 | 1,321 | 12,180 | 360,101 | 358.8 K to 360.1 K (+0.37 %) |
| Jul 10 2013 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Sell | S | 18.06 | 47,864 | 864,424 | 358,780 | 406.6 K to 358.8 K (-11.77 %) |
| Jul 10 2013 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Buy | M | 9.22 | 47,864 | 441,306 | 406,644 | 358.8 K to 406.6 K (+13.34 %) |
| Jul 08 2013 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Option Exercise | M | 9.22 | 21,157 | 195,068 | 49,185 | |
| Jul 08 2013 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Option Exercise | M | 9.22 | 13,505 | 124,516 | 70,342 | |
| Jul 08 2013 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Sell | S | 18.01 | 21,157 | 381,038 | 358,780 | 379.9 K to 358.8 K (-5.57 %) |
| Jul 08 2013 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Buy | M | 9.22 | 21,157 | 195,068 | 379,937 | 358.8 K to 379.9 K (+5.90 %) |
| Jul 08 2013 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Sell | S | 18.01 | 13,505 | 243,225 | 358,780 | 372.3 K to 358.8 K (-3.63 %) |
| Jul 08 2013 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Buy | M | 9.22 | 13,505 | 124,516 | 372,285 | 358.8 K to 372.3 K (+3.76 %) |
| Jun 21 2013 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Option Exercise | M | 9.22 | 1,847 | 17,029 | 83,847 | |
| Jun 21 2013 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Sell | S | 18.00 | 1,847 | 33,246 | 358,780 | 360.6 K to 358.8 K (-0.51 %) |
| Jun 21 2013 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Buy | M | 9.22 | 1,847 | 17,029 | 360,627 | 358.8 K to 360.6 K (+0.51 %) |
| Apr 02 2013 | ANIK | Anika Therapeutics ... | QUINLAN KEVIN W | Chief Financial Off ... | Sell | S | 11.24 | 18,374 | 206,524 | 27,112 | 45.5 K to 27.1 K (-40.39 %) |
| Apr 02 2013 | ANIK | Anika Therapeutics ... | QUINLAN KEVIN W | Chief Financial Off ... | Grant | A | 11.24 | 18,374 | 206,524 | 45,486 | 27.1 K to 45.5 K (+67.77 %) |
| Mar 13 2013 | ANIK | Anika Therapeutics ... | LAND RAYMOND J | Director | Sell | S | 14.00 | 925 | 12,950 | 20,719 | 21.6 K to 20.7 K (-4.27 %) |
| Mar 13 2013 | ANIK | Anika Therapeutics ... | LAND RAYMOND J | Director | Sell | S | 14.00 | 950 | 13,300 | 21,644 | 22.6 K to 21.6 K (-4.20 %) |
| Mar 13 2013 | ANIK | Anika Therapeutics ... | LAND RAYMOND J | Director | Sell | S | 14.00 | 325 | 4,550 | 22,594 | 22.9 K to 22.6 K (-1.42 %) |
| Mar 25 2013 | ANIK | Anika Therapeutics ... | QUINLAN KEVIN W | Chief Financial Off ... | Sell | S | 11.24 | 19,998 | 224,778 | 27,112 | 47.1 K to 27.1 K (-42.45 %) |
| Mar 25 2013 | ANIK | Anika Therapeutics ... | QUINLAN KEVIN W | Chief Financial Off ... | Grant | A | 11.24 | 19,998 | 224,778 | 47,110 | 27.1 K to 47.1 K (+73.76 %) |
| Mar 25 2013 | ANIK | Anika Therapeutics ... | QUINLAN KEVIN W | Chief Financial Off ... | Sell | S | 11.24 | 11,628 | 130,699 | 27,112 | 38.7 K to 27.1 K (-30.02 %) |
| Mar 25 2013 | ANIK | Anika Therapeutics ... | QUINLAN KEVIN W | Chief Financial Off ... | Grant | A | 11.24 | 11,628 | 130,699 | 38,740 | 27.1 K to 38.7 K (+42.89 %) |
| Mar 25 2013 | ANIK | Anika Therapeutics ... | QUINLAN KEVIN W | Chief Financial Off ... | Sell | S | 11.24 | 25,000 | 281,000 | 27,112 | 52.1 K to 27.1 K (-47.97 %) |
| Mar 25 2013 | ANIK | Anika Therapeutics ... | QUINLAN KEVIN W | Chief Financial Off ... | Grant | A | 11.24 | 25,000 | 281,000 | 52,112 | 27.1 K to 52.1 K (+92.21 %) |
| Mar 04 2013 | ANIK | Anika Therapeutics ... | QUINLAN KEVIN W | Chief Financial Off ... | Buy | M | 6.99 | 6,368 | 44,512 | 27,112 | 20.7 K to 27.1 K (+30.70 %) |
| Mar 04 2013 | ANIK | Anika Therapeutics ... | QUINLAN KEVIN W | Chief Financial Off ... | Buy | M | 6.99 | 5,000 | 34,950 | 20,744 | 15.7 K to 20.7 K (+31.76 %) |
| Jan 31 2013 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | Chief Operating Off ... | Option Exercise | A | 10.87 | 41,602 | 452,214 | 41,602 | |
| Jan 31 2013 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | Chief Operating Off ... | Option Exercise | A | 10.87 | 18,398 | 199,986 | 18,398 | |
| Jan 31 2013 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Option Exercise | A | 10.87 | 81,602 | 887,014 | 81,602 | |
| Jan 31 2013 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Option Exercise | A | 10.87 | 18,398 | 199,986 | 18,398 | |
| Jan 31 2013 | ANIK | Anika Therapeutics ... | Moran John C | Director | Grant | A | 0.00 | 2,760 | 0 | 25,419 | 22.7 K to 25.4 K (+12.18 %) |
| Jan 31 2013 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Grant | A | 0.00 | 2,760 | 0 | 86,219 | 83.5 K to 86.2 K (+3.31 %) |
| Jan 31 2013 | ANIK | Anika Therapeutics ... | Thompson Jeffery S | Director | Grant | A | 0.00 | 2,760 | 0 | 19,549 | 16.8 K to 19.5 K (+16.44 %) |
| Jan 31 2013 | ANIK | Anika Therapeutics ... | LAND RAYMOND J | Director | Grant | A | 0.00 | 2,760 | 0 | 22,919 | 20.2 K to 22.9 K (+13.69 %) |
| Jan 31 2013 | ANIK | Anika Therapeutics ... | BOWER JOSEPH I | Director | Grant | A | 0.00 | 2,760 | 0 | 27,139 | 24.4 K to 27.1 K (+11.32 %) |
| Dec 28 2012 | ANIK | Anika Therapeutics ... | BOWER JOSEPH I | Director | Gift | G | 0.00 | 100,000 | 0 | 24,379 | 124.4 K to 24.4 K (-80.40 %) |
| Dec 10 2012 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Buy | M | 1.05 | 22,873 | 24,017 | 358,780 | 335.9 K to 358.8 K (+6.81 %) |
| Dec 10 2012 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Buy | M | 1.05 | 17,127 | 17,983 | 335,907 | 318.8 K to 335.9 K (+5.37 %) |
| Apr 23 2012 | ANIK | Anika Therapeutics ... | BOWER JOSEPH I | Director | Buy | M | 1.05 | 11,800 | 12,390 | 124,379 | 112.6 K to 124.4 K (+10.48 %) |
| Apr 23 2012 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | Chief Operating Off ... | Buy | M | 5.01 | 5,979 | 29,955 | 5,979 | 0 to 6 K |
| Mar 20 2012 | ANIK | Anika Therapeutics ... | LAND RAYMOND J | Director | Sell | S | 11.92 | 1,500 | 17,876 | 20,159 | 21.7 K to 20.2 K (-6.93 %) |
| Mar 20 2012 | ANIK | Anika Therapeutics ... | LAND RAYMOND J | Director | Sell | S | 12.13 | 1,000 | 12,132 | 21,659 | 22.7 K to 21.7 K (-4.41 %) |
| Mar 16 2012 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Payment of Exercise | F | 12.15 | 20,000 | 243,000 | 318,780 | 338.8 K to 318.8 K (-5.90 %) |
| Mar 16 2012 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Buy | M | 1.16 | 37,500 | 43,500 | 338,780 | 301.3 K to 338.8 K (+12.45 %) |
| Mar 16 2012 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Buy | M | 1.05 | 12,500 | 13,125 | 301,280 | 288.8 K to 301.3 K (+4.33 %) |
| Mar 08 2012 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | Chief Operating Off ... | Option Exercise | A | 6.99 | 37,500 | 262,125 | 37,500 | |
| Mar 08 2012 | ANIK | Anika Therapeutics ... | QUINLAN KEVIN W | Chief Financial Off ... | Option Exercise | A | 6.99 | 37,500 | 262,125 | 37,500 | |
| Mar 08 2012 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Option Exercise | A | 6.99 | 75,000 | 524,250 | 75,000 | |
| Feb 03 2012 | ANIK | Anika Therapeutics ... | Thompson Jeffery S | Director | Grant | A | 0.00 | 3,296 | 0 | 16,789 | 13.5 K to 16.8 K (+24.43 %) |
| Feb 03 2012 | ANIK | Anika Therapeutics ... | Moran John C | Director | Grant | A | 0.00 | 3,296 | 0 | 22,659 | 19.4 K to 22.7 K (+17.02 %) |
| Feb 03 2012 | ANIK | Anika Therapeutics ... | BOWER JOSEPH I | Director | Grant | A | 0.00 | 3,296 | 0 | 112,579 | 109.3 K to 112.6 K (+3.02 %) |